COSMAI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 329
EU - Europa 170
AS - Asia 136
Totale 635
Nazione #
US - Stati Uniti d'America 325
IE - Irlanda 118
CN - Cina 115
FI - Finlandia 17
SG - Singapore 15
DE - Germania 9
IT - Italia 6
NL - Olanda 5
CA - Canada 4
JP - Giappone 4
UA - Ucraina 4
RU - Federazione Russa 3
AT - Austria 2
SE - Svezia 2
BG - Bulgaria 1
FR - Francia 1
GB - Regno Unito 1
IR - Iran 1
MY - Malesia 1
RS - Serbia 1
Totale 635
Città #
Dublin 118
Chandler 75
Beijing 31
Ashburn 29
Boardman 23
Nanjing 21
Princeton 21
Dearborn 20
Lawrence 20
Helsinki 14
Wilmington 14
Nanchang 13
Shanghai 13
Medford 11
Singapore 11
Jiaxing 9
Ann Arbor 6
Changsha 6
Jacksonville 4
Meppel 4
New York 4
Tokyo 4
Hangzhou 3
Hebei 3
Kunming 3
Redwood City 3
Shenyang 3
Tianjin 3
Toronto 3
Falkenstein 2
Jinan 2
Los Angeles 2
Milan 2
Norwalk 2
St Petersburg 2
Trieste 2
Woodbridge 2
Ardabil 1
Belgrade 1
Borås 1
Cedar Knolls 1
Dallas 1
Frankfurt am Main 1
Guangzhou 1
Magnago 1
Monmouth Junction 1
Ningbo 1
Ottawa 1
Quanzhou 1
Redmond 1
Rockville 1
Saint Petersburg 1
Sofia 1
Sungai Besar 1
Taizhou 1
Vienna 1
West Columbia 1
Totale 528
Nome #
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines 71
Acute Kidney Injury in Cancer Patients 65
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy 48
Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA 38
Renal effects of targeted anticancer therapies 38
The adjuvant treatment of kidney cancer: a multidisciplinary outlook 35
Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines 33
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis 31
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature 29
Opening an onconephrology clinic: recommendations and basic requirements 28
Transplantation of kidneys with tumors 28
Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: A systematic review and meta-analysis 28
Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) 27
Glomerular diseases and cancer: evaluation of underlying malignancy 27
Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM) 27
Renal cancer in kidney transplanted patients 24
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa’ Italiana di Nefrologia (SIN) multidisciplinary consensus position paper 21
Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all? 21
Renal toxicity of anticancer agents targeting HER2 and EGFR 17
Harmonization of renal function assessment is needed throughout the whole process of anticancer drug development 17
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 5
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 4
Totale 662
Categoria #
all - tutte 4.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 0 0 0 0 0 0 14 20 1 12 20 1
2020/202115 1 2 1 2 1 1 2 2 2 0 1 0
2021/202263 0 0 5 0 0 0 1 2 5 2 13 35
2022/2023263 32 22 13 6 11 21 0 13 137 2 2 4
2023/202490 11 18 1 5 11 24 1 7 0 3 5 4
2024/202560 4 23 5 9 1 18 0 0 0 0 0 0
Totale 662